Patents by Inventor Anne Petit

Anne Petit has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition containing a somatostatin analogue for radiopharmaceutical use
    Patent number: 12329830
    Abstract: The present invention relates to a somatostatin analogue composition for radiopharmaceutical use, in particular for diagnostic or therapeutic use. More specifically the somatostatin analogue is a receptor-selective somatostatin peptide antagonist.
    Type: Grant
    Filed: June 20, 2019
    Date of Patent: June 17, 2025
    Assignee: Ariceum Therapeutics GmbH
    Inventors: Romain Bejot, Bilal Karaaoui, Didier Kubiak, Anne-Claire Le Meur, Didier Nourrisson, Anne Petit, Joel Richard, Camille Toulisse
  • Composition containing a somatostatin analogue for radiopharmaceutical use
    Publication number: 20240366810
    Abstract: The present invention relates to a somatostatin analogue composition for radiopharmaceutical use, in particular for diagnostic or therapeutic use. More specifically the somatostatin analogue is a receptor-selective somatostatin peptide antagonist.
    Type: Application
    Filed: March 19, 2024
    Publication date: November 7, 2024
    Inventors: Marie Delporte, Sabine HOVEST, Jens KAUFMANN, Dennis MEWIS, Anne PETIT, Joel RICHARD
  • Composition containing a somatostatin analogue for radiopharmaceutical use
    Patent number: 11969484
    Abstract: The present invention relates to a somatostatin analogue composition for radiopharmaceutical use, in particular for diagnostic or therapeutic use. More specifically the somatostatin analogue is a receptor-selective somatostatin peptide antagonist.
    Type: Grant
    Filed: June 20, 2019
    Date of Patent: April 30, 2024
    Assignee: Ariceum Therapeutics GmbH
    Inventors: Marie Delporte, Sabine Hovest, Jens Kaufmann, Dennis Mewis, Anne Petit, Joel Richard
  • Composition Containing a Somatostatin Analogue for Radiopharmaceutical Use
    Publication number: 20230181771
    Abstract: The present invention relates to a somatostatin analogue composition for radiopharmaceutical use, in particular for diagnostic or therapeutic use. More specifically the somatostatin analogue is a receptor-selective somatostatin peptide antagonist.
    Type: Application
    Filed: June 20, 2019
    Publication date: June 15, 2023
    Inventors: Marie Delporte, Sabine Hovest, Jens Kaufmann, Dennis Mewis, Anne Petit, Joel Richard
  • Composition Containing a Somatostatin Analogue for Radiopharmaceutical Use
    Publication number: 20210128758
    Abstract: The present invention relates to a somatostatin analogue composition for radiopharmaceutical use, in particular for diagnostic or therapeutic use. More specifically the somatostatin analogue is a receptor-selective somatostatin peptide antagonist.
    Type: Application
    Filed: June 20, 2019
    Publication date: May 6, 2021
    Inventors: Romain Bejot, Bilal Karaaouil, Didier Kubiak, Anne-Claire Le Meur, Didier Nourrisson, Anne Petit, Joel Richard, Camille Toulisse
  • Contrast medium formulation and related preparation method
    Patent number: 10918743
    Abstract: The present invention relates to a liquid pharmaceutical composition including a complex of formula (I), in which M is an ion of a paramagnetic metal and R1 to R3, X1 to X3 and K1 to K12 are such as defined in claim 1, said composition also including a calcium complex of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid. The invention also relates to the preparation method thereof and to an imaging method involving said composition.
    Type: Grant
    Filed: April 28, 2014
    Date of Patent: February 16, 2021
    Assignee: GUERBET
    Inventors: Christelle Medina, Monique Sabatou, Anne Petit, Marc Port
  • Pharmaceutical composition for a sustained release of lanreotide
    Patent number: 10543249
    Abstract: A pharmaceutical composition for a sustained release of peptide therapeutics, in particular for a sustained release compatible with therapeutic treatments of at least two months. In an embodiment, the composition comprises lanreotide as an active agent, a hydrosoluble co-solvent, and water with the pH of the composition being from 4.0 to 7.5.
    Type: Grant
    Filed: July 8, 2014
    Date of Patent: January 28, 2020
    Assignee: IPSEN PHARMA S.A.S.
    Inventors: Ruth Bielsa Guivernau, Roland Cherif-Cheikh, Julie Fournes, Daniel Martinez Lorente, Anne Petit, Joël Richard
  • AQUEOUS SUSTAINED RELEASE COMPOSITIONS OF LHRH ANALOGUES
    Publication number: 20160184386
    Abstract: An aqueous pharmaceutical composition for the sustained release of an LHRH analogue, in particular for a sustained release compatible with therapeutic treatments for at least 2 weeks. The pharmaceutical compositions are particularly useful for the treatment of diseases an LHRH analogue is indicated for.
    Type: Application
    Filed: July 21, 2014
    Publication date: June 30, 2016
    Inventors: Joel RICHARD, Anne PETIT, Jeremiah HARNETT, Marie-Madeleine BARONNET, Franck ARTZNER, Mercedes CARDUS MALESPINA, Roland CHERIF-CHEIKH, Martin MONTES, Marie-Therese PATERNOSTRE, Celine VALERY
  • PHARMACEUTICAL COMPOSITION FOR A SUSTAINED RELEASE OF LANREOTIDE
    Publication number: 20160151447
    Abstract: A pharmaceutical composition for a sustained release of peptide therapeutics, in particular for a sustained release compatible with therapeutic treatments of at least two months. In an embodiment, the composition comprises lanreotide as an active agent, a hydrosoluble co-solvent, and water with the pH of the composition being from 4.0 to 7.5.
    Type: Application
    Filed: July 8, 2014
    Publication date: June 2, 2016
    Inventors: Ruth BIELSA GUIVERNAU, Roland CHERIF-CHEIKH, Julie FOURNES, Daniel MARTINEZ LORENTE, Anne PETIT, Joël RICHARD
  • CONTRAST MEDIUM FORMULATION AND RELATED PREPARATION METHOD
    Publication number: 20160101196
    Abstract: The present invention relates to a liquid pharmaceutical composition including a complex of formula (I), in which M is an ion of a paramagnetic metal and R1 to R3, X1 to X3 and K1 to K12 are such as defined in claim 1, said composition also including a calcium complex of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid. The invention also relates to the preparation method thereof and to an imaging method involving said composition.
    Type: Application
    Filed: April 28, 2014
    Publication date: April 14, 2016
    Applicant: GUERBET
    Inventors: Christelle Medina, Monique Sabatou, Anne Petit, Marc Port